Stock Research for AKRX

Current Price


Latest Update: 2018-02-23 16:00:00

$ 30.1800
$ 30.1100
$ 30.1200

Featured Broker: TradeStation

Get the due diligence for another stock.


AKRX Stock Chart & Research Data

The AKRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the AKRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


AKRX Due diligence Resources & Stock Charts

The AKRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View AKRX Detailed Price Forecast - CNN Money CNN View AKRX Detailed Summary - Google Finance
Yahoo View AKRX Detailed Summary - Yahoo! Finance Zacks View AKRX Stock Research & Analysis -

Stock Analysis

TradeIdeas View AKRX Trends & Analysis - Trade-Ideas Barrons View AKRX Major Holders - Barrons
NASDAQ View AKRX Call Transcripts - NASDAQ Seeking View AKRX Breaking News & Analysis - Seeking Alpha
Spotlight View AKRX Annual Report - OTC Report View AKRX OTC Short Report -
TradeKing View AKRX Fundamentals - TradeKing Charts View AKRX SEC Filings - Bar Chart
WSJ View Historical Prices for AKRX - The WSJ Morningstar View Performance/Total Return for AKRX - Morningstar
MarketWatch View the Analyst Estimates for AKRX - MarketWatch CNBC View the Earnings History for AKRX - CNBC
StockMarketWatch View the AKRX Earnings - StockMarketWatch MacroAxis View AKRX Buy or Sell Recommendations - MacroAxis
Bullish View the AKRX Bullish Patterns - American Bulls Short Pains View AKRX Short Pain Metrics -

Social Media Mentions

StockTwits View AKRX Stock Mentions - StockTwits PennyStocks View AKRX Stock Mentions - PennyStockTweets
Twitter View AKRX Stock Mentions - Twitter Invest Hub View AKRX Investment Forum News - Investor Hub
Yahoo View AKRX Stock Mentions - Yahoo! Message Board Seeking Alpha View AKRX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for AKRX - Insider Cow View Insider Transactions for AKRX - Insider Cow
CNBC View AKRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for AKRX - OTC Markets
Yahoo View Insider Transactions for AKRX - Yahoo! Finance NASDAQ View Institutional Holdings for AKRX - NASDAQ

Stock Charts

FinViz View AKRX Stock Insight & Charts - StockCharts View AKRX Investment Charts -
BarChart View AKRX Stock Overview & Charts - BarChart Trading View View AKRX User Generated Charts - Trading View

Latest Financial News for AKRX

Factors of Influence in 2018, Key Indicators and Opportunity within Akorn, Autodesk, NextEra Energy Partners, LP, Hertz Global, Cinedigm, and Nektar Therapeutics — New Research Emphasizes Economic Growth
Posted on Thursday February 15, 2018

NEW YORK, Feb. 15, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Akorn, ...

Pomerantz LLP and Glancy Prongay & Murray LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Akorn, Inc. - AKRX
Posted on Wednesday February 14, 2018

NEW YORK, NY / ACCESSWIRE / February 14, 2018 / Pomerantz LLP and Glancy Prongay & Murray LLP announce that the United States District Court for the Northern District of Illinois, Eastern Division, has ...

AKRX Investor Alert: Kyros Law is Filing Compensation Claims on Behalf of Akorn Pharmaceuticals (NASDAQ: AKRX) Investors
Posted on Friday February 09, 2018

BOSTON, Feb. 9, 2018 /PRNewswire/ -- Kyros Law Offices is alerting investors of Akorn Pharmaceuticals (AKRX) that it is filing legal claims on behalf of investors against the company for possible securities fraud violations.. Akorn Pharmaceuticals (AKRX) investors that purchased stock BETWEEN MAY 6, 2014 AND APRIL 24, 2015  are urged to contact our law firm immediately to protect their rights. Visit our AKRX Shareholder Lawsuit Settlement webpage or call 1-800-934-2921 to speak to someone about your case.

See what the IHS Markit Score report has to say about Akorn Inc.
Posted on Tuesday February 06, 2018

Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 2. Over the last one-month, outflows of investor capital in ETFs holding AKRX totaled $4.39 billion.

Buy or Sell? Average Brokerage Ratings on Akorn, Inc. (AKRX), Genworth ...
StockNewsJournal - 13 hours ago
Investors who are keeping close eye on the stock of Akorn, Inc. (NASDAQ:AKRX) established that the company was able to keep return on investment at 3.98 in the trailing twelve month while Reuters data showed that industry's average stands at 14.09 and ...
Akorn Inc. (AKRX) Moves Lower on Volume Spike for February 22 -
Headfake or Buy the Momentum Akorn, Inc. (AKRX), Jaguar Health, Inc. (JAGX) - Post Analyst

Hot Stock under Consideration: Akorn Inc (NASDAQ: AKRX)
Alpha Beta Stock - 13 hours ago
U.S. stocks rose on Friday but were still on track to post weekly losses. Wall Street also looked ahead to the release of the Federal Reserve's monetary policy report.

Prominent Runners: Microchip Technology Inc. (NASDAQ:MCHP), Akorn, Inc ...
The Oracle Examiner - 13 hours ago
Akorn, Inc. is a specialty generic pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals.

As Akorn INC (AKRX) Stock Rose, Gardner Lewis Asset Management LP Has Raised Stake
BZ Weekly - Feb 22, 2018
Gardner Lewis Asset Management LP increased its stake in Akorn Inc. (AKRX) by 159.65% based on its latest 2017Q3 regulatory filing with the SEC.
What's in Akorn Inc (NASDAQ:AKRX) After Decline in Shorted Shares? - Frisco Fastball

Enter a stock symbol to view the stock details.